Premium
Transgenic potato expressing Aβ reduce Aβ burden in Alzheimer's disease mouse model
Author(s) -
Youm Jung Won,
Kim Hee,
Han Jee Hye Lo,
Jang Chang Hwan,
Ha Hee Jin,
Mook-Jung Inhee,
Jeon Jae Heung,
Choi Cheol Yong,
Kim Young Ho,
Kim Hyun Soon,
Joung Hyouk
Publication year - 2005
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/j.febslet.2005.11.003
Subject(s) - transgene , genetically modified mouse , amyloid precursor protein , amyloid (mycology) , alzheimer's disease , biology , genetically modified crops , immune system , disease , bace1 as , tandem repeat , gene , immunology , medicine , genome , biochemistry , pathology , botany
Beta amyloid (Aβ) is believed one of the major pathogens of Alzheimer's disease (AD), and the reduction of Aβ is considered a primary therapeutic target. Immunization with Aβ can reduce Aβ burden and pathological features in transgenic AD model mice. Transgenic potato plants were made using genes encoding 5 tandem repeats of Aβ1–42 peptides with an ER retention signal. Amyloid precursor protein transgenic mice (Tg2576) fed with transgenic potato tubers with adjuvant showed a primary immune response and a partial reduction of Aβ burden in the brain. Thus, Aβ tandem repeats can be expressed in transgenic potato plants to form immunologically functional Aβ, and these potatoes has a potential to be used for the prevention and treatment of AD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom